Kite Unveils Novel BCMA-Directed CAR T-cell Therapy – OncLive – OncLive
OncLive |
Kite Unveils Novel BCMA-Directed CAR T-cell Therapy – OncLive
OncLive A novel target, B-cell maturation antigen, has been identified for future therapeutic development as chimeric antigen receptor T-cell therapy for patients with … |
